Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $11.97, $0.89 better than the analyst estimate of $11.08. Revenue for the quarter came in at $48.8 billion versus the consensus estimate of $46.27 billion.

GUIDANCE:

Elevance Health Inc. sees FY2025 EPS of $34.15-$34.85, versus the consensus of $34.19.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.